FXN and hyperinsulinemic hypoglycemia, familial, 4: Current strategies for the treatment of FRDA mainly focused on correcting frataxin expression, which intervenes the pathogenetic cascade downstream of frataxin deficiency, enhance antioxidant expression, and even some further gene or protein replacement or cellular therapies6,33.